ATE552867T1 - Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon - Google Patents

Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon

Info

Publication number
ATE552867T1
ATE552867T1 AT07765405T AT07765405T ATE552867T1 AT E552867 T1 ATE552867 T1 AT E552867T1 AT 07765405 T AT07765405 T AT 07765405T AT 07765405 T AT07765405 T AT 07765405T AT E552867 T1 ATE552867 T1 AT E552867T1
Authority
AT
Austria
Prior art keywords
collagen matrix
production method
cell device
matrix cell
coated collagen
Prior art date
Application number
AT07765405T
Other languages
English (en)
Inventor
Denis Dufrane
Pierre Rene Raymond Gianello
Jan Egil Melvik
Original Assignee
Fmc Biopolymer As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As
Application granted granted Critical
Publication of ATE552867T1 publication Critical patent/ATE552867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT07765405T 2006-06-16 2007-06-13 Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon ATE552867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81440406P 2006-06-16 2006-06-16
PCT/EP2007/055857 WO2007144389A2 (en) 2006-06-16 2007-06-13 Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof

Publications (1)

Publication Number Publication Date
ATE552867T1 true ATE552867T1 (de) 2012-04-15

Family

ID=38666842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07765405T ATE552867T1 (de) 2006-06-16 2007-06-13 Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon

Country Status (5)

Country Link
US (1) US8168215B2 (de)
EP (1) EP2029727B1 (de)
AT (1) ATE552867T1 (de)
ES (1) ES2386123T3 (de)
WO (1) WO2007144389A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
EP2152860A4 (de) * 2007-06-13 2011-12-07 Fmc Corp Peptidgebundene zellmatrixmaterialien für stammzellen und ihre verwendung
AU2008266060B2 (en) * 2007-06-13 2013-08-29 Fmc Corporation Alginate coated, polysaccharide gel-containing foam composite, preparative methods, and uses thereof
RU2391399C2 (ru) * 2008-07-31 2010-06-10 Государственное Образовательное Учреждение Высшего Профессионального Образования "Красноярский Государственный Медицинский Университет Имени Профессора В.Ф. Войно-Ясенецкого Министерства Здравоохранения И Социального Развития Российской Федерации" (Гоу Впо Красгму Им.Проф.В.Ф.Войно-Ясенецкого) Способ получения клеточной матрицы кожи
US9540630B2 (en) 2008-09-17 2017-01-10 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
US9446168B2 (en) 2010-06-07 2016-09-20 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
DE102010001179A1 (de) * 2010-01-25 2011-07-28 Technische Universität Dresden, 01069 Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
HRP20200310T1 (hr) * 2010-10-06 2020-08-21 President And Fellows Of Harvard College Hidrogelovi koji stvaraju pore pogodni za injekcije, namijenjeni staničnim terapijama na bazi materijala
US20130336940A1 (en) 2011-02-23 2013-12-19 Universite Catholique De Louvain Modified pig islets for diabetes treatment
KR101327630B1 (ko) * 2012-03-05 2013-11-13 울산대학교 산학협력단 아텔로콜라겐을 이용한 췌도세포 이식용 담체의 제조방법 그리고 이를 이용하여 제조된 인공췌장
GB201301618D0 (en) * 2013-01-30 2013-03-13 Ge Healthcare Uk Ltd Solid medium for the storage of Biological Material
EP2968646B1 (de) * 2013-03-13 2019-05-29 AlloSource Faszienfaserzusammensetzungen und verfahren zu deren verwendung und herstellung
US10202636B2 (en) * 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
ES2769813T3 (es) 2014-04-11 2020-06-29 Univ Catholique Louvain Islotes transgénicos de cerdo y usos de los mismos para el tratamiento de la diabetes
EP3149026B1 (de) * 2014-06-02 2025-03-05 B.G. Negev Technologies and Applications Ltd. Stellenselektive modifikation von polysacchariden und anwendungen davon
WO2016061450A1 (en) * 2014-10-16 2016-04-21 Beth Israel Deaconess Medical Center, Inc. Collagen-alginate constructs and uses thereof
US11471419B2 (en) 2016-09-30 2022-10-18 The Board Of Trustees Of The University Of Illinois Capsules with intracapsular microspheres for improved survival and function of encapsulated cells
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
EP4225336A4 (de) * 2020-10-09 2024-11-20 The Regents of The University of California Immunengineering von biomaterialien zur behandlung von transplantatabstossung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2128551A (en) * 1934-01-11 1938-08-30 Algin Corp Of America Method of treating seaweed
US2036934A (en) * 1934-04-21 1936-04-07 Kelco Co Process for making alginic acid and product
US2426125A (en) * 1944-04-03 1947-08-19 Kelco Co Manufacture of glycol alginates
US3772266A (en) * 1972-10-19 1973-11-13 Kelco Co Process for the preparation of propylene glycol alginate from partially neutralized alginic acid
CA1019326A (en) * 1974-07-16 1977-10-18 Uniroyal Ltd. Process for the production of alkylene glycol alginates
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
US5429821A (en) 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
RU2208636C2 (ru) * 1994-01-13 2003-07-20 Дзе Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
CA2214088A1 (en) * 1995-03-03 1996-09-12 Metabolex Inc. Novel encapsulation process by a gelling polymer
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
US6126936A (en) * 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US6419920B1 (en) * 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
JP4335316B2 (ja) * 1996-09-19 2009-09-30 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン アルギネートまたは修飾アルギネートのようなポリサッカライドを含むポリマー
US6171610B1 (en) * 1998-04-24 2001-01-09 University Of Massachusetts Guided development and support of hydrogel-cell compositions
ATE412733T1 (de) * 1999-01-21 2008-11-15 Adv Med Solutions Ltd Träger zum zellwachstum
US6699470B1 (en) * 1999-10-12 2004-03-02 Massachusetts Institute Of Technology Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
ATE360063T1 (de) * 2000-10-12 2007-05-15 Agency Science Tech & Res Nicht störendes, dreidimensionales system für die kultivierung und ernte verankerungsabhängiger zellen
EP2228035A1 (de) * 2003-12-23 2010-09-15 FMC Biopolymer AS Verwendung von Alginatmatrizen zur Steuerung des Zellwachstums
US7790699B2 (en) * 2004-10-12 2010-09-07 Fmc Biopolymer As Self-gelling alginate systems and uses thereof

Also Published As

Publication number Publication date
WO2007144389A3 (en) 2008-02-14
US8168215B2 (en) 2012-05-01
EP2029727B1 (de) 2012-04-11
WO2007144389A2 (en) 2007-12-21
US20080050417A1 (en) 2008-02-28
EP2029727A2 (de) 2009-03-04
ES2386123T3 (es) 2012-08-09

Similar Documents

Publication Publication Date Title
WO2007144389A3 (en) Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof
FR23C1028I1 (fr) Mutant de polypeptide du facteur ix, ses utilisations et son procédé de production
MX368000B (es) Composición de colágeno y ácido hialurónico para la reparación de ligamento o tendón.
EP4131408C0 (de) Anzeigesubstrat und herstellungsverfahren dafür sowie anzeigevorrichtung
BR112013027307A2 (pt) método para tratar uma matriz de tecido; matriz de tecido acelular
CY1123085T1 (el) Yδρογελες θειïκου αλγινικου αλατος για κυτταρικη καλλιεργεια και θεραπεια
MX344581B (es) Reticulantes borónicos multifuncionales y métodos asociados.
EP1896177A4 (de) Kobaltoxidkatalysator zur wasserstofferzeugung und herstellungsverfahren dafür
EA201070074A1 (ru) Разлагаемые гели для применения для разобщения зон
BRPI0914809A2 (pt) aparelho de display e método de fabricação do mesmo, e substrato de matriz ativa
ATE539721T1 (de) Vorrichtung zur wundbehandlung
EP2002484A4 (de) Verfahren und struktur für die herstellung von solarzellen mittels schichtübertragungsverfahren
SE0800807L (sv) Nytt förfarande
EP2452537A4 (de) Mobilstation, basisstation und betriebsverfahren für die mobilstation
MY162957A (en) Polymer foam cell morphology control and use in borehole filtration devices
ATE429320T1 (de) Medizinische vorrichtung und herstellungsverfahren dafür
SG148142A1 (en) Aryloazol-2-yl cyanoethylamino compunds, method of making and method of using thereof
ATE536192T1 (de) Vernetzte hyaluronsäure und kollagen und ihre verwendungen
BRPI0920741A2 (pt) diamante policristalino, compactado de diamante policristalino, método de fabricação do mesmo, e suas diversas aplicações.
DE602008000105D1 (de) Lagermatte, dessen Herstellungsverfahren, Abgasbehandlungsvorrichtung und dessen Herstellungsverfahren und Dämpfungsvorrichtung
EP2295563A4 (de) B-amylase, dafür codierendes gen und herstellungsverfahren dafür
EP2573125A4 (de) Konjugiertes polymer mit dithienpyrrol-chinoxalin, herstellungsverfahren und verwendung
WO2010077266A9 (en) Method of dynamic binary temperature therapy
EP2011861A4 (de) Bakterium mit fähigkeit zur produktion einer purinsubstanz und verfahren zur produktion der purinsubstanz
MY158569A (en) Treatment of biofuels